| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 17.530 | 24.553 | 27.793 | 37.660 | 38.779 | 30.582 | 34.105 | 56.233 | 43.294 | 33.501 |
| Total Income - EUR | 17.530 | 24.554 | 27.794 | 37.661 | 38.779 | 30.592 | 34.129 | 56.252 | 44.297 | 33.522 |
| Total Expenses - EUR | 13.948 | 13.901 | 14.965 | 20.653 | 24.376 | 14.233 | 14.226 | 15.312 | 8.015 | 11.622 |
| Gross Profit/Loss - EUR | 3.582 | 10.652 | 12.829 | 17.008 | 14.403 | 16.359 | 19.903 | 40.940 | 36.283 | 21.900 |
| Net Profit/Loss - EUR | 3.056 | 9.916 | 11.995 | 15.878 | 13.239 | 15.503 | 19.102 | 39.495 | 31.220 | 18.417 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bioharcom S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.218 | 817 | 673 | 15.610 | 11.655 | 7.827 | 4.126 | 1.337 | 818 | 1.322 |
| Current Assets | 6.199 | 15.123 | 15.439 | 10.208 | 22.535 | 11.520 | 19.835 | 49.059 | 50.016 | 23.409 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 500 | 1.842 | 1.877 | 2.642 | 4.204 | 1.599 | 361 | 8.942 | 9.664 | 5.105 |
| Cash | 5.700 | 13.280 | 13.562 | 7.567 | 18.331 | 9.921 | 19.475 | 40.117 | 40.352 | 18.305 |
| Shareholders Funds | 5.504 | 11.133 | 13.155 | 17.232 | 30.138 | 16.597 | 20.172 | 40.626 | 41.398 | 20.382 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.913 | 4.807 | 2.957 | 8.586 | 4.052 | 2.750 | 3.790 | 9.769 | 9.436 | 4.349 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9103 - 9103" | |||||||||
| CAEN Financial Year |
9103
|
|||||||||
Comments - Bioharcom S.r.l.